GGrantIndex
Sort

39,280 grants matching leukemia

Comparative Analysis of Genetic Interaction Networks

$480,934
Trey Ideker · University Of California, San Diego · R01 · FY2014 · GM

STUDIES ON VITAMIN D AND CALCIUM METABOLISM

$480,875
University Of California Riverside · R01 · FY2003 · DK

Restoration of Tumor Suppression Activity in Malignant Melanoma

$480,848
David Joseph Weber · University Of Maryland Baltimore · R01 · FY2011 · CA

Intervening with Smoking Parents of Inpatients to Reduce Exposure

$480,835
Gwendolyn S Kerby · University Of Colorado Denver · R01 · FY2017 · CA

Molecular and Cellular Immunology

$480,799
Anthony L. Defranco · University Of California, San Francisco · T32 · FY2014 · AI

Specific Adoptive Immunotherapy of Leukemia

$480,639
Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA

Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)

$480,601
William L. Carroll · New York University School Of Medicine · R01 · FY2011 · CA

Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes

$480,567
Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2019 · HL

Clinical Investigation of Epigenetic Therapy

$480,497
John C Byrd · Ohio State University · P01 · FY2008 · CA

Targeting MicroRNAs to Eradicate Leukemia Stem Cells

$480,469
Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN

$480,447
Alexander Sparreboom · St. Jude Children'S Research Hospital · R01 · FY2007 · CA

Inhibition of Bcl-xL by Targeted Degradation

$480,430
Guangrong Zheng · University Of Florida · R01 · FY2024 · CA

DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES

$480,370
Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

Regenerative Therapies for Inherited Blood Disorders-Gene therapy

$480,358
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

Quantitative protein network profiling to improve CAR design and efficacy

$480,325
Stephen Edward Paucha Smith · Seattle Children'S Hospital · R01 · FY2022 · CA

Quantitative protein network profiling to improve CAR design and efficacy

$480,325
Stephen Edward Paucha Smith · Seattle Children'S Hospital · R01 · FY2023 · CA

Defining Epidrivers of CLL Evolution in Response to Targeted Therapy

$480,304
Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA

Studies of Populations Exposed to Diagnostic Medical Radiation

$480,266
Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES

$480,257
Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia

$480,193
Amy Paguirigan · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Flow Cytometric Evaluation of Biomarkers

$480,138
Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA

Targeting the LIFR-LCN2 pathway to improve liver cancer therapy

$480,131
Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Off-the-Shelf Engineered Cord Blood NK Cells for the Treatment of Hematologic Malignancies.

$480,131
Katy Rezvani · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA

Targeting the LIFR-LCN2 pathway to improve liver cancer therapy

$480,131
Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections

$480,128
Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI